Media playback is unsupported on your device

Diabetes drug may slow Alzheimer's

10 December 2013 Last updated at 20:06 GMT

A trial has begun to see whether a drug used to treat diabetes can slow the progression of Alzheimer's disease.

The 200 patients on the trial will receive a daily injection of liraglutide or a placebo for 12 months, and will have scans and memory tests before and after the treatment.

Research suggests that the drug reduces brain inflammation, improving the growth of brain cells and the connections between them.

Fergus Walsh reports.

Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.